Clinical Trials Browser

Phase 1 × Multiple Myeloma × Immunotherapy, Adoptive × Clear all

NCT07340853 2026-03-10

CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma

NCT03448978 2024-07-01

Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

Phase 1 Terminated

Multiple Myeloma